| Central Kansas Podiatry Associates | |
|
613 N Main St, El Dorado, KS 67042-2027 | |
| (316) 269-3338 | |
| (316) 264-5516 |
| Full Name | Central Kansas Podiatry Associates |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 613 N Main St, El Dorado, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194929711 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Central Kansas Podiatry Associates 933 N Topeka St, Wichita, KS 67214-3620 Ph: (316) 269-3338 | Central Kansas Podiatry Associates 613 N Main St, El Dorado, KS 67042-2027 Ph: (316) 269-3338 |
News Archive
Researchers from the University of Bern, Inselspital, Bern University Hospital and the Swiss Center for Electronics and Microtechnology develop a high-precision, sensor-based surgical robot for spinal operations together with industry partners.
Taxanes are a family of compounds that includes one of the most important cancer drugs ever discovered, Taxol, among other cancer treatments. But the difficulty producing these complex molecules in the lab has hampered or blocked exploration of the family for further drug leads. Now, a group of Scripps Research Institute scientists has successfully achieved a major step toward the goal of synthetically producing Taxol and other complex taxanes on a quest to harness chemical reactions that could enable research on previously unavailable potential drugs.
diaDexus, Inc., a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the commercial launch of its CE-marked PLAC Test for Lp-PLA(2) Activity in Europe.
Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.
› Verified 4 days ago
Dr. Larry L Abraham, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 321 N Main St, El Dorado, KS 67042 Phone: 316-321-2050 Fax: 316-321-3309 | |
Dr. Nicholas J Posge, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 700 W Central Ave Ste 105, El Dorado, KS 67042 Phone: 316-322-9813 Fax: 316-322-9806 |